{"disease":{"id":"allergic-bronchopulmonary-aspergillosis","name":"Allergic bronchopulmonary aspergillosis","therapeutic_area":"","data":{},"enrichment_level":0,"last_enriched_at":null,"visit_count":0,"created_at":"2026-04-19T18:31:21.150Z","updated_at":"2026-04-19T18:39:44.960Z","meddra_pt":null,"meddra_code":null,"icd10_codes":null,"synonyms":[],"prevalence_global":null,"prevalence_us":null,"marketed_drug_count":2,"pipeline_drug_count":0,"trial_count":3},"drugs":{"marketed":[{"drug_id":"prednisolone","indication_name":"Allergic bronchopulmonary aspergillosis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Prelone","generic_name":"prednisolone","company_name":"Generic (originally Schering)","drug_phase":"marketed","molecular_target":"Annexin A1, Corticosteroid-binding globulin, G-protein coupled bile acid receptor 1","drug_class":"Glucocorticoid (corticosteroid)","quality_score":40,"revenue":null,"mechanism":""},{"drug_id":"prednisolon","indication_name":"Allergic bronchopulmonary aspergillosis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"prednisolon","company_name":"Hannover Medical School","drug_phase":"marketed","molecular_target":"Annexin A1, Corticosteroid-binding globulin, G-protein coupled bile acid receptor 1","drug_class":"","quality_score":null,"revenue":null,"mechanism":null}],"pipeline":[],"offLabel":[],"totalMarketed":2,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06645210","title":"Multicenter Registration Study on Allergic Bronchopulmonary Aspergillosis","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":300,"lead_sponsor_name":"Peking University Third Hospital","has_results":false},{"nct_id":"NCT03059992","title":"Study to Evaluate the Efficacy and Safety of Ibrexafungerp in Patients With Fungal Diseases That Are Refractory to or Intolerant of Standard Antifungal Treatment","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":233,"lead_sponsor_name":"Scynexis, Inc.","has_results":true},{"nct_id":"NCT07493629","title":"Immune Status and Disease Control of Inflammatory Airway Diseases","phase":"","overall_status":"RECRUITING","enrollment_count":200,"lead_sponsor_name":"First Affiliated Hospital of Ningbo University","has_results":false},{"nct_id":"NCT02273661","title":"Evaluation of a Therapeutic Strategy Including Nebulised Liposomal Amphotericin B (Ambisome®) in Maintenance Treatment of Allergic Bronchopulmonary Aspergillosis (Cystic Fibrosis Excluded).","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":174,"lead_sponsor_name":"Poitiers University Hospital","has_results":false},{"nct_id":"NCT07040332","title":"Pathogenesis and Inflammatory Phenotype of Allergic Bronchopulmonary Aspergillosis","phase":"","overall_status":"RECRUITING","enrollment_count":140,"lead_sponsor_name":"Qianfoshan Hospital","has_results":false},{"nct_id":"NCT05444946","title":"Oral Itraconazole Versus Combination of Systemic Glucorticoids and Oral Itraconazole in CPA-ABPA Overlap Syndrome","phase":"NA","overall_status":"RECRUITING","enrollment_count":104,"lead_sponsor_name":"Post Graduate Institute of Medical Education and Research, Chandigarh","has_results":false},{"nct_id":"NCT05129033","title":"A Prospective Study on Optimizing Treatment for ABPA","phase":"NA","overall_status":"UNKNOWN","enrollment_count":100,"lead_sponsor_name":"Shanghai Zhongshan Hospital","has_results":false},{"nct_id":"NCT07055230","title":"Interest of IgE Directed Against Recombinant Antigens of Aspergillus Fumigatus in the Diagnosis of Allergic Bronchopulmonary Aspergillosis (ABPA)","phase":"","overall_status":"COMPLETED","enrollment_count":67,"lead_sponsor_name":"University Hospital, Rouen","has_results":false},{"nct_id":"NCT04442269","title":"Investigating Treatment With Dupilumab in Patients With Allergic Bronchopulmonary Aspergillosis (ABPA) (LIBERTY ABPA AIRED)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":62,"lead_sponsor_name":"Regeneron Pharmaceuticals","has_results":true},{"nct_id":"NCT04229303","title":"Phase 1 Three Part SAD, MAD & Cross-Over Study of ZP-059 in Healthy and Asthmatic Subjects","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":58,"lead_sponsor_name":"Zambon SpA","has_results":true},{"nct_id":"NCT07362693","title":"A Cohort Study of the Efficacy and Safety of Biologics in Patients With ABPA","phase":"","overall_status":"RECRUITING","enrollment_count":50,"lead_sponsor_name":"Qianfoshan Hospital","has_results":false},{"nct_id":"NCT07362667","title":"A Study of the Efficacy and Safety of Bronchoscopic Airway Clearance and Amphotericin B Spraying in Patients With ABPA","phase":"","overall_status":"RECRUITING","enrollment_count":44,"lead_sponsor_name":"Qianfoshan Hospital","has_results":false},{"nct_id":"NCT04476758","title":"Immune Profiles in CF Fungal Infection","phase":"","overall_status":"COMPLETED","enrollment_count":24,"lead_sponsor_name":"University of Alabama at Birmingham","has_results":false},{"nct_id":"NCT07530770","title":"Real-World Effectiveness of Benralizumab in Allergic Bronchopulmonary Aspergillosis","phase":"","overall_status":"RECRUITING","enrollment_count":20,"lead_sponsor_name":"Qianfoshan Hospital","has_results":false},{"nct_id":"NCT06244979","title":"iMagIng pulmonaRy Aspergillosis Using Gallium-68-dEferoxamine","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":10,"lead_sponsor_name":"Radboud University Medical Center","has_results":false},{"nct_id":"NCT03960606","title":"Study in Adult Asthmatic Patients With Allergic Bronchopulmonary Aspergillosis","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":7,"lead_sponsor_name":"Pulmatrix Inc.","has_results":false},{"nct_id":"NCT05616338","title":"Modeling Bronchial Epithelium in Severe Asthma With Human Induced Pluripotent Stem Cells (iPSC)","phase":"NA","overall_status":"COMPLETED","enrollment_count":4,"lead_sponsor_name":"University Hospital, Montpellier","has_results":false},{"nct_id":"NCT04108962","title":"Benralizumab in the Treatment of Patients With Severe Asthma With ABPA","phase":"PHASE4","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"Baylor Research Institute","has_results":false},{"nct_id":"NCT05903612","title":"Allergic Bronchopulmonary Aspergillosis Prescreening Study","phase":"","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"Community Pharmacology Services Ltd","has_results":false},{"nct_id":"NCT05897294","title":"Voriconazole Inhalation Powder for the Treatment of Pulmonary Aspergillosis","phase":"","overall_status":"NO_LONGER_AVAILABLE","enrollment_count":null,"lead_sponsor_name":"TFF Pharmaceuticals, Inc.","has_results":false}],"total":20},"guidelines":[],"source":"Drug Landscape verified database"}